ELÍA, ANDRES; SALDAIN, LEO; LOVISI, SILVIA; MARTÍNEZ VAZQUEZ, PAULA; BURRUCHAGA, JAVIER; LAMB, CAROLINE A.; LÜTHY, ISABEL ALICIA; DIEZ, FEDERICO; HOMER, NATALIE Z M; ANDREW, RUTH; ROJAS, PAOLA; LANARI, CLAUDIA

Steroid profile in patients with breast cancer and in mice treated with mifepristone

Endocrine-related cancer; Lugar: Bristol; Año: 2024 vol. 31

ANDRÉS ELIA; GABRIELA PATACCINI; LEO SALDAIN; LUISA AMBROSIO ; CLAUDIA LANARI ; PAOLA ROJAS 2

Antiprogestins for breast cancer treatment: We are almost ready

Journal of Steroid Biochemistry and Molecular Biology; Año: 2024 vol. 241

ABASCAL, MARÍA FLORENCIA; ELIA, ANDRÉS; ALVAREZ, MICHELLE; PATACCINI, GABRIELA; SEQUEIRA, GONZALO; RIGGIO, MARINA; FIGUEROA, VIRGINIA; LAMB, CAROLINE A.; ROJAS, PAOLA A.; SPENGLER, EUNICE; MARTÍNEZ-VAZQUEZ, PAULA; BURRUCHAGA, JAVIER; LIGUORI, MARCOS; SAHORES, ANA; WARGON, VICTORIA; MOLINOLO, ALFREDO; HEWITT, STEPHEN; LOMBES, MARC; SARTORIUS, CAROL; VANZULLI, SILVIA INÉS; GIULIANELLI, SEBASTIÁN; LANARI, CLAUDIA

Progesterone receptor isoform ratio dictates antiprogestin/progestin effects on breast cancer growth and metastases: A role for NDRG1

INTERNATIONAL JOURNAL OF CANCER. JOURNAL INTERNATIONAL DU CANCER.; Año: 2022

CARABIAS, PABLO; ESPELT, MARÍA V.; BACIGALUPO, MARÍA L.; ROJAS, PAOLA; SARRIAS, LUCIANA; RUBIN, AYELÉN; SAFFIOTI, NICOLÁS A.; ELOLA, MARÍA T.; ROSSI, JUAN P.; WOLFENSTEIN-TODEL, CARLOTA; RABINOVICH, GABRIEL A.; TRONCOSO, MARÍA F.

Galectin-1 confers resistance to doxorubicin in hepatocellular carcinoma cells through modulation of P-glycoprotein expression

Cell Death and Disease; Año: 2022 vol. 13

ANDRÉS ELÍA ; LEO SALDAIN ; SILVIA I VANZULLI ; LUISA A HELGUERO; CAROLINE A LAMB ; VICTORIA FABRIS; GABRIELA PATACCINI; PAULA MARTÍNEZ-VAZQUEZ ; JAVIER BURRUCHAGA ; INES CAILLET-BOIS ; EUNICE SPENGLER ; GABRIELA ACOSTA HAAB; MARCOS LIGUORI ; ALEJANDRA CASTETS ; SILVIA LOVISI ; MARÍA F ABASCAL ; VIRGINIA NOVARO ; JANA SÁNCHEZ; JAVIER MUÑOZ ; JOSE M BELIZÁN; MARTÍN C ABBA ; HUGO GASS ; PAOLA ROJAS 2; CLAUDIA LANARI

Beneficial effects of mifepristone treatment in breast cancer patients selected by the progesterone receptor isoform ratio: Results from the MIPRA trial

CLINICAL CANCER RESEARCH; Lugar: Philadelphia; Año: 2022 vol. 1 p. 1 - 1

SAHORES, ANA; FIGUEROA, VIRGINIA; MAY, MARÍA; LIGUORI, MARCOS; RUBSTEIN, ADRIÁN; FUENTES, CYNTHIA; JACOBSEN, BRITTA M.; ELÍA, ANDRÉS; ROJAS, PAOLA; SEQUEIRA, GONZALO R.; ÁLVAREZ, MICHELLE M.; GONZÁLEZ, PEDRO; GASS, HUGO; HEWITT, STEPHEN; MOLINOLO, ALFREDO; LANARI, CLAUDIA; LAMB, CAROLINE A.

Increased High Molecular Weight FGF2 in Endocrine-Resistant Breast Cancer

Hormones and Cancer; Año: 2018 vol. 9 p. 338 - 348

ROJAS, PAOLA A.; MAY, MARÍA; SEQUEIRA, GONZALO R.; ELIA, ANDRÉS; ALVAREZ, MICHELLE; MARTÍNEZ, PAULA; GONZALEZ, PEDRO; HEWITT, STEPHEN; HE, XIAPING; PEROU, CHARLES M.; MOLINOLO, ALFREDO; GIBBONS, LUZ; ABBA, MARTIN C.; GASS, HUGO; LANARI, CLAUDIA

Progesterone Receptor Isoform Ratio: A Breast Cancer Prognostic and Predictive Factor for Antiprogestin Responsiveness

JOURNAL OF THE NATIONAL CANCER INSTITUTE.; Año: 2017 vol. 109

MAY, MARÍA; MOSTO, JULIÁN; VAZQUEZ, PAULA MARTINEZ; GONZALEZ, PEDRO; ROJAS, PAOLA; GASS, HUGO; LANARI, CLAUDIA; MOLINOLO, ALFREDO A.

Nuclear staining of fgfr-2/stat-5 and runx-2 in mucinous breast cancer

EXPERIMENTAL AND MOLECULAR PATHOLOGY.; Año: 2016 vol. 100 p. 39 - 44

WARGON V; RIGGIO M; GIULIANELLI S; SEQUEIRA GR; ROJAS P; MAY M; POLO ML; GOROSTIAGA MA; JACOBSEN B; MOLINOLO A; NOVARO V; LANARI C

Progestin and antiprogestin responsiveness in breast cancer is driven by the PRA/PRB ratio via AIB1 or SMRT recruitment to the CCND1 and MYC promoters

INTERNATIONAL JOURNAL OF CANCER. JOURNAL INTERNATIONAL DU CANCER.; Lugar: New York; Año: 2015 vol. 1 p. 2680 - 2692

GONZALO SEQUEIRA; VANZULLI SI; ROJAS P; LAMB C; COLOMBO L; MAY M; MOLINOLO A; LANARI C

The effectiveness of nano chemotherapeutic particles combined with mifepristone depends on the PR isoform ratio in preclinical models of breast cancer

Oncotarget; Lugar: New York; Año: 2014 vol. 5 p. 3246 - 3260

PONTILLO CA; ROJAS P; CHIAPPINI F; SEQUEIRA G; COCCA C; CROCCI M; COLOMBO L; LANARI C; KLEIMAN DE PISAREV D; RANDI A

Action of hexachlorobenzene on tumor growth and metastasis in different experimental models

TOXICOLOGY AND APPLIED PHARMACOLOGY; Lugar: Amsterdam; Año: 2013 vol. 1 p. 331 - 342

CLAUDIA LANARI; VICTORIA WARGON; PAOLA ROJAS; ALFREDO MOLINOLO

Antiprogestins in breast cancer treatment: are we ready?

ENDOCRINE - RELATED CANCER; Lugar: Bristol; Año: 2012 p. 35 - 50

A. BRUZZONE; C.P. PIÑERO; P. ROJAS; M. ROMANATO; H. GASS; C. LANARI; I.A. LUTHY

alpha 2-Adrenoceptors enhance cell proliferation and mammary tumor growth acting through both the stroma and the tumor cells

CURRENT CANCER DRUG TARGETS; Año: 2011 vol. 11 p. 721 - 736

BOTTINO MC; CERLIANI JP; ROJAS P; GIULIANELLI S; SOLDATI R; MONDILLO C; GOROSTIAGA MA; PIGNATARO OP; CALVO JC; GUTKIND JS; PANOMWAT AMORNPHIMOLTHAM; MOLINOLO AA; LÜTHY IA; LANARI C.

Classical membrane progesterone receptors in murine mammary carcinomas: agonistic effects of progestins and RU-486 mediating rapid non-genomic effects.

BREAST CANCER RESEARCH AND TREATMENT; Lugar: New York; Año: 2011 p. 621 - 636

IBAÑEZ IL; POLICASTRO LL; TROPPER I; BRACALENTE C; PALMIERI MA; ROJAS PA; MOLINARI BL; DURÁN H

H(2)O(2) scavenging inhibits G1/S transition by increasing nuclear levels of p27(KIP1)

CANCER LETTERS; Año: 2011 vol. 1 p. 58 - 68

CLAUDIA LANARI; VIRGINIA NOVARO; CAROLINA LAMB; VICTORIA FABRIS; PAOLA ROJAS; SEBASTIÁN GIULIANELLI; MARÍA GOROSTIAGA; VICTORIA WARGON; TOMÁS GUILLARDOY; MARÍA LAURA POLO; MARINA RIGGIO; GONZALO SEQUEIRA; ANA SAHORES; MARÍA PAMPENA

Crecimiento del cáncer de mama

ACTA BIOQUíMICA CLíNICA LATINOAMERICANA; Lugar: La Plata; Año: 2011 vol. 45 p. 659 - 662

ROJAS P; BENAVIDES F; BLANDO J; PEREZ C; CARDENAS K; RICHIE E; KNUDSEN ES; JOHNSON DG; SENDEROWICZ AM; RODRIGUEZ-PUEBLA ML; CONTI CJ

Enhanced skin carcinogenesis and lack of thymus hyperplasia in transgenic mice expressing human cyclin D1b (CCND1b).

MOLECULAR CARCINOGENESIS.; Año: 2008 p. 1 - 10

WARGON V; HELGUERO LA; BOLADO J; ROJAS P; NOVARO V; MOLINOLO A; LANARI C

Reversal of antiprogestin resistance and progesterone receptor isoform ratio in acquired resistant mammary carcinomas.

BREAST CANCER RESEARCH AND TREATMENT; Año: 2008 p. 1 - 10

BRUZZONE A; PIÑERO CP; CASTILLO LF; SARAPPA MG; ROJAS P; LANARI C; LUTHY IA

Alpha2-adrenoceptor action on cell proliferation and mammary tumour growth in mice.

BRITISH JOURNAL OF PHARMACOLOGY; Año: 2008 vol. 155 p. 494 - 504

PAOLA ROJAS; MARIA BELÉN CADENAS; PEI-CHUN LIN; FERNANDO BENAVIDES; PIOTR SICINSKI,; CLAUDIO J. CONTI; MARCELO L. RODRIGUEZ-PUEBLA

Cyclin D2 and cyclin D3 play opposite roles in mouse skin carcinogenesis

ONCOGENE; Año: 2006 vol. 15 p. 1723 - 1730

POLICASTRO L; MOLINARI B; LARCHER F,; BLANCO P; PODHAJCER O; COSTA CS; ROJAS P; DURAN H

Imbalance of Antioxidant Enzymes in Tumor Cells and Inhibition of Proliferation and Malignant Features by Scavenging Hydrogen Peroxide

MOLECULAR CARCINOGENESIS.; Año: 2004 vol. 39 p. 103 - 113

ECHEVERRIA PC; ROJAS PA,; MARTIN V; GUARNERA EA; PSZENNY V; ANGEL SO

Characterisation of a novel interspersed Toxoplasma gondii DNA repeat with potential uses for PCR diagnosis and PCR-RFLP analysis.

FEMS MICROBIOLOGY LETTERS; Año: 2000 vol. 1 p. 23 - 27

ROJAS PA; MARTIN V,; NIGRO M; ECHEVERRIA PC; GUARNERA EA,; PSZENNY V; ANGEL SO

Expression of a cDNA encoding a Toxoplasma gondii protein belonging to the heat- shock 90 family and analysis of its antigenicity

FEMS MICROBIOLOGY LETTERS; Año: 2000 vol. 190 p. 209 - 213